CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
Dallas, Texas, United States and 10 other locations
single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...
Phase 2
Dallas, Texas, United States and 2 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...
Phase 3
Dallas, Texas, United States and 72 other locations
recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...
Phase 1
Dallas, Texas, United States and 5 other locations
Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH,...
Phase 1
Dallas, Texas, United States
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Dallas, Texas, United States and 220 other locations
period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate...
Phase 1
Dallas, Texas, United States and 16 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Dallas, Texas, United States and 388 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Dallas, Texas, United States and 249 other locations
A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...
Phase 1
Dallas, Texas, United States and 100 other locations
Clinical trials
Research sites
Resources
Legal